|
3
|
11
|
5q1eB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q11B |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q15B |
Ligand binding to farnesoid-x-receptor |
|
3
|
13
|
5q0xB |
Ligand binding to farnesoid-x-receptor |
|
2
|
10
|
5q13B |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q0tB |
Ligand binding to farnesoid-x-receptor |
|
2
|
11
|
5q0zB |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q0yB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q0rB |
Ligand binding to farnesoid-x-receptor |
|
2
|
9
|
5q0qB |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q1fB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q1bB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q0pB |
Ligand binding to farnesoid-x-receptor |
|
3
|
11
|
5q1cB |
Ligand binding to farnesoid-x-receptor |
|
2
|
12
|
5q0wB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q0oB |
Ligand binding to farnesoid-x-receptor |
|
3
|
12
|
5q1aB |
Ligand binding to farnesoid-x-receptor |
|
2
|
11
|
5ow7B |
Vdr complex |
|
2
|
10
|
5ow9B |
Vitamin d receptor complex |
|
2
|
11
|
5owdB |
Vitamin d receptor complex |
|
38
|
114
|
5owkA |
Crystal structure of crebbp bromodomain complexed with dspb2a002 |
|
27
|
107
|
5nwxA |
Insight into the molecular recognition mechanism of the coactivator ncoa1 by stat6 |
|
43
|
119
|
5nu3A |
Crystal structure of the human bromodomain of crebbp bound to the inhibitor xdm-cbp |
|
20
|
132
|
5nwmA |
Insight into the molecular recognition mechanism of the coactivator ncoa1 by stat6 |
|
43
|
116
|
5nu5A |
Crystal structure of the human bromodomain of ep300 bound to the inhibitor xdm-cbp |
|
38
|
115
|
5nlkA |
Crystal structure of crebbp bromodomain complexd with us13a |
|
38
|
115
|
5nrwA |
Crystal structure of the human bromodomain of crebbp bound to the inhibitor xdm4 |
|
2
|
10
|
5nmaB |
Structure-activity relationship study of vitamin d analogs with oxolane group in their side chain |
|
2
|
10
|
5nkyB |
Structure-activity relationship study of vitamin d analogs with oxolane group in their side chain |
|
41
|
119
|
5mmeA |
Crystal structure of crebbp bromodomain complexd with us46c |
|
2
|
10
|
5l7gB |
Mcr in complex with ligand |
|
45
|
116
|
5lpjA |
Crystal structure of the bromodomain of human crebbp bound to the inhibitor xdm1 |
|
41
|
119
|
5lplA |
Crystal structure of the bromodomain of human crebbp bound to the inhibitor xdm3c |
|
79
|
278
|
5j9wA |
Crystal structure of the nua4 core complex |
|
37
|
107
|
5ktuA |
Crystal structure of the bromodomain of human crebbp bound to pyrazolopiperidine scaffold |
|
13
|
42
|
5jemC |
Complex of irf-3 with cbp |
|
1
|
9
|
5jmmF |
Crystal structure of hera-lbd (y537s) in complex with biochanin a |
|
61
|
195
|
5hh0A |
Crystal structure of human naa60 in complex with coa |
|
40
|
118
|
5h85A |
Crystal structure of the bromodomain of human crebbp in complex with uo37d |
|
55
|
180
|
5icvA |
Crystal structure of human natf (hnaa60) bound to a bisubstrate analogue |
|
59
|
211
|
5hgzA |
Crystal structure of human naa60 in complex with acetyl-coa |
|
42
|
164
|
5h84A |
Human gcn5 bound to propionyl-coa |
|
52
|
180
|
5icwA |
Crystal structure of human natf (hnaa60) homodimer bound to coenzyme a |
|
5
|
15
|
5hjsC |
Identification of lxrbeta selective agonists for the treatment of alzheimer's disease |
|
59
|
195
|
5hh1A |
Crystal structure of human naa60 mutant - f34a in complex with coa |
|
41
|
115
|
5i89A |
Crystal structure of the bromodomain of human crebbp bound to the benzodiazepinone g02857790 |
|
44
|
167
|
5h86A |
Human gcn5 bound to butyryl-coa |
|
3
|
11
|
5aztC |
Ternary complex of hpparalpha ligand binding domain, 17-oxodha and a src1 peptide |
|
3
|
11
|
5gtoB |
Human ppargamma ligand binding dmain complexed with s35 |
|
42
|
113
|
5gh9A |
Crystal structure of cbp bromodomain with h3k56ac peptide |
